Alliance Pharma plc is a UK-based global pharmaceutical company, which acquires, markets, and distributes pharmaceutical products across the world. It was founded in the year 1996 and its headquarters are situated in the United Kingdom. The company is listed and traded on the London Stock Exchange publicly and complies with the UK City Code on Takeovers and Mergers. The subsidiaries of Alliance Pharma include Biogix, Inc., Opus Health Care AB, Caraderm Limited, Alliance Pharmaceuticals Ltd, and Cambridge Laboratories Limited. The company has had over 15 acquisitions in the past 10 years and generated 72% of its revenue from consumer healthcare brands in 2020. Alliance Pharma sells its products in more than 100 countries and holds the marketing rights for around 80 consumer healthcare brands and prescription medicines. The areas of business which the company covers include community and consumer products, international products, secondary care etc. The company focuses on various therapeutic areas, like oncology, gastroenterology, dermatology, central nervous system, endocrinology, obstetrics, and gynecology etc.
The main goal of the company is to become the leading international healthcare business and maximize the returns for all its stakeholders, which include patients, healthcare providers, business partners and investors. It aims to build clinically valuable products to satisfy the specific needs of the patients and maximize the potential of its brand. The products of the company are categorized as medical devices, prescription only medicines, over the counter medications, and nutritional & cosmetics supplements. Some products offered by Alliance pharma are and Ashton & Parsons Infants' Powders, ImmuCyst 81mg, Anbesol Adult Strength Gel, Lift Plus, Hydromol etc.
Alliance Pharma plc follows a well-defined framework of corporate governance and aligns itself with an ethical code of conduct for running its business operations. It complies with the Quoted Companies Alliance (QCA) Corporate Governance Code and promotes a culture of transparency, integrity, and accountability. The board of the company has set up separate committees for Audit and Risk, Remuneration and Nomination, and follows strict policies regarding board diversity and inclusion, gender pay gap etc. It focuses on building a business model that helps in achieving long-term growth and creating value for all shareholders, while considering its social responsibilities and the impact of its activities on the wider community.
In addition to its corporate and social responsibilities, the company also fulfils its environmental responsibilities and strives for sustainable business solutions. It has a comprehensive ESG framework in place and tries to reduce its environmental footprint and make a long-lasting social contribution for a better future of the planet. It is also engaged in volunteer work and works with its charity partners ‘International Health partners’ to create a positive impact on the society.
Avonbridge House, Bath Road SN15 2BB United Kingdom